Mysore S Anil Kumar
Overview
Explore the profile of Mysore S Anil Kumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
237
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malat G, Boyle S, Jindal R, Guy S, Xiao G, Harhay M, et al.
Am J Kidney Dis
. 2018 Apr;
73(1):112-118.
PMID: 29705074
Hahnemann University Hospital has performed 120 kidney transplantations in human immunodeficiency virus (HIV)-positive individuals during the last 16 years. Our patient population represents ∼10% of the entire US population of...
2.
Anil Kumar M, Papp K, Tainaka R, Valluri U, Wang X, Zhu T, et al.
Biopharm Drug Dispos
. 2018 Apr;
39(5):245-255.
PMID: 29679478
This study evaluated the pharmacokinetics (PK), efficacy, safety, and tolerability of bleselumab - a fully-human anti-CD40 monoclonal recombinant IgG4. Patients with moderate-to-severe psoriasis were randomized on day 1 to receive...
3.
Bayer N, Cochetti P, Anil Kumar M, Teal V, Huan Y, Doria C, et al.
Transplantation
. 2010 Aug;
90(8):861-6.
PMID: 20724958
Background: New-onset diabetes after transplantation (NODAT) is a major posttransplant complication associated with lower allograft and recipient survival. Our objective was to determine whether metabolic syndrome pretransplant is independently associated...
4.
Malat G, Culkin C, Palya A, Ranganna K, Anil Kumar M
Drugs
. 2009 Oct;
69(15):2045-62.
PMID: 19791826
Among organ transplant recipients, the African American population historically has received special attention. This is because secondary to their disposition to certain disease states, for example hypertension, an African American...
5.
Anil Kumar M, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar A, et al.
Transpl Immunol
. 2008 Sep;
20(1-2):32-42.
PMID: 18773960
Induction and maintenance immunosuppression protocols with or without long-term steroid therapy in kidney transplant recipients are variable and are transplant center-specific. The aim of this prospective randomized pilot study was...
6.
Anil Kumar M, Khan S, Jaglan S, Heifets M, Moritz M, Saeed M, et al.
Transplantation
. 2007 Jan;
82(12):1640-5.
PMID: 17198251
Background: Kidneys from deceased donors with acute renal failure (ARF) are generally not accepted for transplantation because of the expected poor outcome. This prospective study examined the utilization of kidneys...
7.
Anil Kumar M, Heifets M, Moritz M, Saeed M, Khan S, Fyfe B, et al.
Transplantation
. 2006 Mar;
81(6):832-9.
PMID: 16570004
Background: Chronic steroid therapy in spite of myriad side effects is widely used in kidney transplantation. This prospective controlled study evaluated safety and efficacy of steroid withdrawal at 2 days...
8.
Anil Kumar M, Heifets M, Fyfe B, Saaed M, Moritz M, Parikh M, et al.
Transplantation
. 2005 Oct;
80(6):807-14.
PMID: 16210969
Background: Chronic steroid therapy in kidney transplantation has myriad side effects and steroid avoidance has become feasible. This prospective study compared the safety and efficacy of steroid avoidance in tacrolimus...
9.
Anil Kumar M, Moritz M, Saaed M, Heifets M, Sustento-Reodica N, Fyfe B, et al.
Am J Transplant
. 2005 Jul;
5(8):1976-85.
PMID: 15996248
African American (AA) kidney recipients receive chronic steroid therapy to improve outcomes, despite their high susceptibility to side effects, particularly diabetes and hypertension. This study evaluated the safety and efficacy...
10.
Anil Kumar M, Sierka D, Damask A, Fyfe B, McAlack R, Heifets M, et al.
Kidney Int
. 2005 Mar;
67(4):1622-9.
PMID: 15780120
Background: Human immunodeficiency virus-associated nephropathy (HIVAN) has become the third leading cause of end-stage renal disease (ESRD) in African Americans, and is expected to grow exponentially. Highly active antiretroviral therapy...